XML 20 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
9 Months Ended
May 31, 2021
May 31, 2020
Cash flows from operating activities:    
Net earnings (loss) $ 1,899 $ 68
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 1,455 1,447
Deferred income taxes (210) (102)
Stock compensation expense 120 101
Equity (earnings) loss from equity method investments 577 (297)
Goodwill and intangible impairments 0 2,001
Loss on early extinguishment of debt 419 0
Gain on sale of equity method investment (290) 0
Other (141) 305
Changes in operating assets and liabilities:    
Accounts receivable, net (897) 141
Inventories 71 (227)
Other current assets 18 59
Trade accounts payable 927 (210)
Accrued expenses and other liabilities 428 569
Income taxes 54 (353)
Other non-current assets and liabilities (120) (102)
Net cash provided by operating activities 4,310 3,398
Cash flows from investing activities:    
Additions to property, plant and equipment (1,001) (962)
Proceeds from sale-leaseback transactions 662 557
Proceeds from sale of other assets 406 52
Business, investment and asset acquisitions, net of cash acquired (1,394) (345)
Other (14) 37
Net cash used for investing activities (1,341) (660)
Cash flows from financing activities:    
Net change in short-term debt with maturities of 3 months or less 1,556 196
Proceeds from debt 12,720 16,336
Payments of debt (11,050) (16,871)
Stock purchases (110) (1,374)
Proceeds related to employee stock plans 41 40
Cash dividends paid (1,212) (1,260)
Early debt extinguishment (3,687) 0
Other (114) (66)
Net cash used for financing activities (1,856) (2,998)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (55) (3)
Changes in cash, cash equivalents and restricted cash:    
Net increase (decrease) in cash, cash equivalents, and restricted cash 1,058 (263)
Cash, cash equivalents and restricted cash at beginning of period 746 1,207
Cash, cash equivalents and restricted cash at end of period $ 1,803 $ 943